Peptide data sheet
GHRP-2
Performance · Pralmorelin · KP-102 · GHRP2
Verdict
unprovenas a physique or aging-related agent
Quick answer
GHRP-2 (pralmorelin) is a synthetic growth hormone releasing peptide that acts on the ghrelin receptor to prompt the pituitary to release growth hormone. Early human studies measured real, short-term rises in GH and IGF-1 markers, which is why it was explored as a GH-testing tool. It is not approved by regulators, is sold for research use only, and reported effects include higher cortisol, prolactin, and appetite. The verdict stays Unproven for physique or aging-related use.
- Class
- Growth hormone secretagogue (ghrelin-receptor agonist)
- Half-life
- Short — roughly 15 to 30 minutes reported in pharmacokinetic studies
- FDA status
- Not FDA-approved; sold for research use only
- WADA banned?
- Yes
Which form actually works?
Injectable (research vial)
Unproven
The form studied in the human GH-response and diagnostic literature. It moves GH markers short-term, but human data on physique or aging-related outcomes is missing, and sourcing is gray-market.
Oral / nasal
Unproven
Sometimes marketed in these forms, but peptide bioavailability by these routes is poorly characterized and there is little supporting human data. Considered unproven.